Replies to post #347432 on Innovation Pharmaceuticals Inc (IPIX)

[Cognition]

Great post! I was going to point out the 5.3 person breakdown in my response but figured I gave him enough. But then again for TIAB it’s never enough!

[falcon74]

JFM...another excellent post

You, Pete, Farrell and a few others have really helped in keeping this board on track as to the progress IPIX is making!!

I think your opinions/thoughts are spot on and that is why longs will have a great weekend and looking forward to some great news from Leo in the near future.

Gosh.......I would HATE to be SHORT on this stock!!

[williamssc]

Could be some of these Russian clinics on that list don't have a choice in anti-virals and B is the only choice. Russia to my understanding is a mostly poor country. Go B

[farrell90]

I agree the high number of sites is a surprise. We know from the US experience how regional Covid19 can be.I expect some of the sites will have 15-20 patients in the study while others will have 3 or 4 or may be even none due to the hot spots which can develop with Covid 19.

An excellent plan to quickly complete the study.

GLTA,

Farrell

[Jeritron5100]

Sell when Leo sells

[To infinity and beyond!]

5.3 per 20 sites a big advantage? Sure if your goal is enrolling patients very quickly. Or if you have very large multi center trials where you need a large N.

Is that the case here? No.

They oughta be able to find 10-20 patients easily at 1/2 to 1/4 of the sites and then life would be simpler for standardization and running the trial. No no need for 20. Too many cooks.

Also- they only need 120 people(or 106). It is not like a very large cardiology trial, just to take one example, where you recruit thousands of patients. Again, no need for 20 sites. Small trial.

Am I personally glad if they run it quick and fast? Sure if it works. Then more news sooner.

If you are right about the start they should know a great deal of data right this very minute.

I think you are wrong and the trial has not enrolled anyone